ADRs |
Adverse drug reactions |
aAEDs |
Aromatic antiepileptic drugs |
AGEP |
Acute Generalized Exanthematous Pustulosis |
ALDEN |
Algorithm of drug causality for epidermal necrolysis |
ALP |
Allopurinol |
BrdU FITC |
Bromodeoxyuridine fluorescein isothiocyanate assay |
CBA |
Cytokine beads array |
CD |
Cluster of differentiation |
CTLA4 |
Cytotoxic T-lymphocyte-associated protein 4 |
DHRs |
Drug hypersensitivity reactions |
DRESS |
Drug Rash with Eosinophilia and Systemic Symptoms |
ELISA |
Enzyme-linked immunosorbent assay |
ELISpot |
Enzyme-linked immunospot assay |
FACS |
Fluorescence-activated cell sorting |
GrB |
Granzyme B |
Grl |
Granulysin |
HLA |
Human Leukocyte Antigens |
ICM |
Iodinated contrast media |
IFNg |
Interferon γ |
IL |
Interleukin |
LTT |
Lymphocyte transformation test |
NA |
Not applicable |
ND |
Not determined |
OXP |
Oxpurinol |
PBMC |
Peripheral blood mononuclear cells |
PD-L1 |
Programmed cell death-ligand 1 |
RegiSCAR |
Registry of severe cutaneous adverse drug reactions |
ROC |
Receiver operator characteristic curve |
RT-PCR |
Reverse transcription polymerase chain reaction |
SCARs |
Severe cutaneous adverse drug reactions |
sFasL |
Soluble factor-related apoptosis ligand |
SJS |
Stevens–Johnson Syndrome |
SMX |
Sulfamethoxazole |
TCR |
T-cell receptor |
TEN |
Toxic Epidermal Necrolysis |
TNFa |
Tumor necrosis factor α |
TRM |
Trimethoprim |